Disclosures for "A Retrospective Study of Urgent MRIs for Detection of ARIA in Lecanemab-treated Patients"
-
Miss Fredrickson has nothing to disclose.
-
Ms. Karwa has nothing to disclose.
-
Dr. Charisis has nothing to disclose.
-
Miss Bennett has nothing to disclose.
-
Mrs. Milano has nothing to disclose.
-
Dr. Dickson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for I-Mab Biopharma.
-
The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
-
The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
-
Author has nothing to disclose
-
Dr. Erkkinen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.